Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2013. The report details a corporate action regarding the admission of shares to the Official List of the London Stock Exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a share issuance rather than a financial results report.
Material Changes
The material change reported is the application to the Financial Services Authority and the London Stock Exchange for the admission of 5,000 ordinary shares of 25p each to the Official List. These shares are reserved under a block listing for issuance pursuant to the GlaxoSmithKline ShareSave 2012 Scheme.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly addresses the administrative process of the block listing application.
Investor Verification Points
- Confirmation that 5,000 shares were reserved under the GlaxoSmithKline ShareSave 2012 Scheme.
- Verification that the shares rank pari passu with existing ordinary shares upon issuance.
- Confirmation of the application date of April 4, 2013, signed by Victoria Whyte, Company Secretary.